Overview
What is Heart Initiative Inc?
Heart Initiative Inc, formerly known as the African Heart Initiative, is a nonprofit organization based in Chapel Hill, North Carolina. Their primary mission is to diagnose and investigate early diagnosis and treatment of cardiovascular diseases, with a specific focus on heart failure, in countries with limited medical resources. In 2022, they have been actively enrolling, summarizing, and analyzing the STRONG HF study, a global, double-blind, placebo-controlled trial assessing the implementation of approved, generic medication for heart failure in patients recently admitted for acute heart failure. The goal is to improve treatment options for the approximately 6 million Americans affected by heart failure. They are also analyzing and publishing data from completed studies in Sub-Saharan Africa and exploring the conduct of new studies to implement robust heart failure treatment globally. Two initiatives launched this year include CORTAHF in collaboration with INSERM in Paris to explore the effects of steroids in acute heart failure, and CP&R, which aims to improve adherence to treatment in patients with hypertension.
Official website here: www.worldheartinitiative.org
Is Heart Initiative Inc legitimate?
Heart Initiative Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Heart Initiative Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.worldheartinitiative.org
What is the mission statement of Heart Initiative Inc?
Heart Initiative Inc, formerly known as African Heart Initiative, is a non-profit organization with a mission to diagnose and explore various aspects of early diagnosis and treatment of cardiovascular diseases, specifically heart failure, in countries where proper medical treatment is severely lacking. In 2022, the organization has been actively enrolling, summarizing, and analyzing the Strong HF study, a multi-center double-blind placebo-controlled study assessing the implementation of approved, generic medication for the treatment of heart failure in patients recently admitted for acute heart failure. The study has enrolled the last 300 out of the predicted 1,100 patients, with the results analyzed, presented, and published. These findings are expected to have a significant impact on the treatment of heart failure, a disease affecting approximately 6 million Americans and associated with high morbidity and mortality. Additionally, Heart Initiative Inc is continuing to analyze and publish data from completed studies conducted in Sub-Saharan Africa and exploring the conduct of other studies to implement robust heart failure treatment globally. New initiatives this year include CortAHF in collaboration with INSERM in Paris to explore the effects of steroids in acute heart failure, and CP&R exploring ways to improve adherence to treatment in patients with hypertension.
Official website here: www.worldheartinitiative.org
Who is the CEO of Heart Initiative Inc?
Beth Cotter-Davison is the Director of Heart Initiative Inc.
Official website here: www.worldheartinitiative.org
What is the revenue of Heart Initiative Inc?
Heart Initiative Inc's revenue in 2022 was $3,129,053.
Official website here: www.worldheartinitiative.org
Who are the executives of Heart Initiative Inc and what are their salaries?
- Gad Cotter (Director)
- Beth Cotter-Davison (Director)
- Robert Molina (Director)
Official website here: www.worldheartinitiative.org
Where can I find the form 990 for Heart Initiative Inc?
The Heart Initiative Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.worldheartinitiative.org
Learn more at the official website: www.worldheartinitiative.org
Mission Statement of Heart Initiative Inc
Heart Initiative Inc, formerly known as African Heart Initiative, is a non-profit organization with a mission to advance the early diagnosis and treatment of cardiovascular diseases, particularly heart failure, in countries where access to proper medical care is severely limited. The organization's primary focus is on third-world nations, aiming to alleviate the burden of heart failure, a disease that affects an estimated 6 million Americans and is associated with high morbidity and mortality.
In pursuit of its mission, Heart Initiative Inc is conducting the STRONG HF study, a multi-center, double-blind, placebo-controlled trial assessing the implementation of approved, generic medication for the treatment of heart failure in patients recently admitted for acute heart failure. As of 2022, the organization has enrolled and analyzed data from the last 300 of the predicted 1,100 patients. The results of this study are expected to have a significant impact on the treatment of heart failure globally.
In addition to the STRONG HF study, Heart Initiative Inc is also analyzing and publishing data from completed studies in Sub-Saharan Africa. The organization is actively exploring the conduct of other studies to help implement the results of robust heart failure treatments globally. This year, Heart Initiative Inc has initiated collaborations with INSERM in Paris for the CORTAHF study, aiming to explore the effects of steroids in acute heart failure, and with CP&R to explore ways to improve adherence to treatment in patients with hypertension.
Impact
This information is meant to be a general summary of Heart Initiative Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Heart Initiative Inc's impact is significant in the field of cardiovascular disease, particularly heart failure. Through their HEART INITIATIVE program, they have conducted the Strong HF study which has enrolled and analyzed a substantial number of patients globally. The results of this study have been presented and published, with the potential to have a significant impact on the treatment of heart failure, a condition affecting millions of Americans with high morbidity and mortality rates.
Furthermore, Heart Initiative Inc is actively analyzing and publishing data from completed studies, including those conducted in underserved regions in Sub-Saharan Africa. They are also exploring the conduct of new studies, such as the CORTAHF study in collaboration with INSERM in Paris, to investigate the effects of steroids in acute heart failure. Additionally, they are working on the CP&R study to enhance treatment adherence in hypertension patients.
By focusing on early diagnosis and treatment of cardiovascular diseases, particularly in third world countries where medical resources are scarce, Heart Initiative Inc is making a significant contribution to improving the quality of care for individuals affected by heart failure.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2009
Phone
(919) 287-1824
Principal Officer
Beth Cotter-Davison
Main Address
50101 GOVERNORS DR, CHAPEL HILL, NC, 275179517
Website
www.worldheartinitiative.org
NTEE Category
Code: G43 - Disease
If you are a representative of Heart Initiative Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.